Literature DB >> 8295944

Antinociceptive and hypothermic crosstolerance between continuous and intermittent cold-water swims in rats.

Z Pavlovic1, R J Bodnar.   

Abstract

Antinociceptive responses induced by continuous (CCWS: 2 degrees C, 3 min) and intermittent (ICWS: 2 degrees C, 18 10-s swims, 18 10-s recoveries) cold-water swims differ in their sensitivity to opioid antagonists and crosstolerance with morphine. The present study examined whether CCWS and ICWS antinociception and hypothermia displayed crosstolerance in rats. Jump thresholds were significantly increased following acute exposure to CCWS (30 min) and ICWS (30-60 min). CCWS antinociception displayed tolerance (90% reduction) to CCWS after 14 days and crosstolerance (100% reduction) to ICWS on the fifteenth day. ICWS antinociception displayed tolerance (74% reduction) to ICWS and crosstolerance (81% reduction) to CCWS. Core body temperatures were significantly decreased following acute exposure to CCWS (30 min) and ICWS (30-90 min). Although CCWS and ICWS hypothermia displayed tolerance to the same stressor and crosstolerance to the other stressor, the changes in the antinociceptive and hypothermic effects failed to correlated significantly with each other.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295944     DOI: 10.1016/0031-9384(93)90328-d

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  3 in total

1.  Analgesia induced by swim stress: interaction between analgesic and thermoregulatory mechanisms.

Authors:  Iwona B Łapo; Marek Konarzewski; Bogdan Sadowski
Journal:  Pflugers Arch       Date:  2003-04-16       Impact factor: 3.657

Review 2.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

3.  The Molecular Signatures of Acute-immobilization-induced Antinociception and Chronic-immobilization-induced Antinociceptive Tolerance.

Authors:  Jing-Hui Feng; Hee-Jung Lee; Hong-Won Suh
Journal:  Exp Neurobiol       Date:  2019-12-31       Impact factor: 3.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.